Continuous Glucose Monitoring– tag –
-
Smart Contact Lenses Advance Glucose and Ocular Pressure Monitoring, with FDA-Approved Devices for Glaucoma
EyeWiki Unknown Overview Smart contact lenses are evolving beyond vision correction to non-invasively monitor glucose levels in tears and intraocular pressure. The Sensimed Triggerfish, an FDA-approved device, already tracks ocular press... -
Dexcom Reaffirms CGM Benefits for All People with Diabetes, Expands to Preventive Care with Stelo App Relaunch and Nutrisense Acquisition at ADA 2026
DexCom, Inc. USA Overview Dexcom announced favorable results from the CONNECT randomized controlled trial at ADA 2026, reaffirming CGM's benefits for non-insulin using type 2 diabetes patients. The company also launched early access to i... -
Glucotrack to Showcase Implantable Continuous Blood Glucose Monitoring with 3-Year Lifespan at ADA Sessions
MarketScreener USA Overview Glucotrack is poised to highlight its innovative implantable Continuous Blood Glucose Monitoring (CBGM) technology at the American Diabetes Association's 2026 Scientific Sessions. The Glucotrack CBGM system of... -
From PPG to Microneedles: The Next Frontier in Non-Invasive Glucose Monitoring
Zimmer & Peacock UK Overview Wearable technology is rapidly evolving from fitness tracking to medical-grade biosensing, particularly in continuous glucose monitoring (CGM). This article explains why photoplethysmography (PPG) is unsuitab... -
Abbott Secures CE Mark for World’s First Dual Glucose-Ketone Sensor, Revolutionizing DKA Management
MedTech Dive USA Overview Abbott has received European CE Mark approval for its Libre Duo and Libre Duo 10 Day systems, the world's first dual-analyte sensors capable of continuously measuring both glucose and ketones. This technology ai... -
Dexcom Battles Black Market for Decommissioned CGM Sensors, Warns of Patient Safety Risks
Businesswire (PRF Technologies経由) USA Overview Dexcom, a prominent diabetes technology firm, has disclosed a significant security breach involving the theft and illicit resale of decommissioned continuous glucose monitoring (CGM) senso... -
Dexcom CGM Receives FDA Breakthrough Designation for In-Hospital Glucose Monitoring
HCPLive USA Overview Dexcom's continuous glucose monitoring (CGM) technology has been granted Breakthrough Device Designation by the U.S. FDA for use in hospital settings. This landmark decision is poised to revolutionize inpatient gluco... -
Microneedle-Based Enzymatic Biosensors Revolutionize Continuous Glucose Monitoring: A Comprehensive Review
ResearchGate (学術論文レビュー) Germany Overview Microneedle (MN) and biosensor technologies are emerging as innovative solutions for both painless drug delivery and real-time diagnostics. This comprehensive review specifically examines ... -
FDA Clears Dexcom Stelo: First Over-the-Counter Continuous Glucose Monitor to Transform Non-Insulin-Dependent Diabetes Management
U.S. Food and Drug Administration (FDA) News Release USA Overview The U.S. FDA has cleared the Dexcom Stelo Glucose Biosensor System, the first over-the-counter (OTC) continuous glucose monitor (CGM) for individuals aged 18 and older not... -
Washington State University Unveils Minimally Invasive Wireless Microneedle Glucose Sensor for Smarter Diabetes Management
ICT&health Netherlands Overview Washington State University researchers have developed a new wearable biosensor to significantly enhance glucose monitoring for diabetes patients. This technology combines microneedles, advanced catalytic ...
